Live feed
·
INSIDERFilingvia Quantisnow
Cyclerion Therapeutics Inc. logo

Cyclerion Therapeutics (CYCN) executive Hecht received 482,950 units

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Peter M Hecht (executive at Cyclerion Therapeutics Inc., CYCN) reported that they received 482,950 units between Jan 3, 2022 and Jan 20, 2022.

Reporting person
Hecht Peter M

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 3, 2022Grant or award (A)Employee Stock Option (Right to Buy)On 52,950 Common Stock1+52,950--52,950 direct
Jan 20, 2022Grant or award (A)Employee Stock Option (Right to Buy)On 430,000 Common Stock2+430,000--430,000 direct

Holdings before and after

  • Employee Stock Option (Right to Buy): 0 to 430,000 direct

Footnotes from the filing

  1. 1. The stock option vests and becomes exercisable as to 8.33333% of the shares of Common Stock on each monthly anniversary of January 3, 2022.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Hecht report in this CYCN Form 4?

Peter M Hecht (executive at Cyclerion Therapeutics Inc., CYCN) reported that they received 482,950 units between Jan 3, 2022 and Jan 20, 2022.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for CYCN

Earlier insider filings at CYCN

Quantisnow market dataNASDAQ
Cyclerion Therapeutics Inc. logo
CYCN
Cyclerion Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for CYCN

Follow CYCN and get a push notification the moment its next story breaks.

Full CYCN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYCN (Cyclerion Therapeutics Inc.) and more on Quantisnow.